Sign in

CIK 0001321834 · Non-accelerated filer<br>Smaller reporting company

Q/C TECHNOLOGIES, INC.

Sign in to watch
Ticker
QCLS
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
856-848-8698
Business address
1185 AVENUE OF THE AMERICAS, SUITE 249, NEW YORK, NY, 10036
Former names
Q/C TECHNOLOGIES, INC., TNF Pharmaceuticals, Inc., MyMD Pharmaceuticals, Inc., Akers Biosciences, Inc., Akers Biosciences Inc
  1. 8-K Event Acquisition or sale completed · Shareholder rights changed · Change in control · Executive or director change · Bylaws or fiscal year change · Regulation FD disclosure · Other events
  2. 4 Insider Changes in Ownership
  3. 3 Insider Initial Statement of Ownership
  4. 4 Insider Changes in Ownership
  5. 4 Insider Changes in Ownership
  6. 4 Insider Changes in Ownership
  7. 3 Insider Initial Statement of Ownership
  8. 3 Insider Initial Statement of Ownership
  9. 4 Insider Changes in Ownership
  10. 3 Insider Initial Statement of Ownership
  11. 4 Insider Changes in Ownership
  12. 4 Insider Changes in Ownership
  13. 4 Insider Changes in Ownership
  14. 8-K Event Shareholder vote results
  15. UPLOAD Other SEC-generated Letter
  16. 425 Deal Prospectus/Communication re Business Combination
  17. 425 Deal Prospectus/Communication re Business Combination
  18. S-3 Offering Registration Statement
  19. EFFECT Other Notice of Effectiveness
  20. 424B3 Offering Prospectus

Page 13 of 31 · 604 filings